In order to further demonstrate the role of APOBEC3A in influencing immune microenvironment of OC, we separated cancer patients into two different APOBEC3A expression cohorts according to the median level and finally identified 187 DEGs by comparing these two groups (Figure 5A). This evidence concerns the gene APOBEC3A and cancer.